The Board of Directors of Beacon Pharmaceuticals Ltd. has recommended 16% cash dividend for the year ended on June 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
159.8 BDT | +3.16% |
|
-3.27% | -34.78% |
1st Jan change | Capi. | |
---|---|---|
-34.78% | 31Cr | |
+20.13% | 4.37TCr | |
+25.15% | 2.28TCr | |
+19.25% | 1.55TCr | |
+18.32% | 1.43TCr | |
+55.47% | 1.28TCr | |
-0.05% | 678.76Cr | |
-11.76% | 651.62Cr | |
+12.62% | 558.78Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- BEACONPHAR Stock
- News Beacon Pharmaceuticals PLC
- Beacon Pharmaceuticals Ltd. Recommends Cash Dividend for the Year Ended on June 30, 2022